|
| |
| | | 67230 | | 22.10.2020 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 01.99. | | | | 01.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Mayzent 0.25 mg | Filmtabletten | Coated tablets (Siponimodum 0.25 mg) | L04AA42 | CI | | 02 | Mayzent 2.00 mg | Filmtabletten | Coated tablets (Siponimodum 2 mg) | L04AA42 | | | 03 | Mayzent 1.00 mg | Filmtabletten | Coated tablets (Siponimodum 1 mg) | L04AA42 | |
|
|
|
